U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466953) titled 'Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality' on March 08.
Brief Summary: This study aims to evaluate the potential effects of mesenchymal stem cell-derived suspended exosome therapy on facial skin quality using objective imaging analysis. Thirty adult participants will receive intradermal exosome applications in three treatment sessions performed at one-month intervals. Facial skin analysis will be conducted using the VISIA imaging system before each treatment session and six months after the final treatment. The study will examine changes in multiple facial skin characteristics including ...